Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2012 - 2026)

Gilead Sciences (GILD) has reported Non-Current Deferred Tax Liability for 11 consecutive years, with $392.0 million the latest figure, recorded in Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $392.0 million, down 44.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $392.0 million (down 44.71% YoY), and the FY2025 annual result was $402.0 million, down 44.48% from the prior year.
• Non-Current Deferred Tax Liability was $392.0 million for Q1 2026 at Gilead Sciences, down from $402.0 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $3.7 billion in Q1 2022 and troughed at $392.0 million in Q1 2026.
• Average Non-Current Deferred Tax Liability over 5 years is $1.6 billion, with a median of $933.0 million recorded in 2024.
• Year-over-year, Non-Current Deferred Tax Liability fell 17.41% in 2022 and slumped 61.14% in 2024.
• Over 5 years, Non-Current Deferred Tax Liability stood at $2.7 billion in 2022, then tumbled by 40.59% to $1.6 billion in 2023, then slumped by 54.41% to $724.0 million in 2024, then plunged by 44.48% to $402.0 million in 2025, then fell by 2.49% to $392.0 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $392.0 million in Q1 2026, $402.0 million in Q4 2025, and $597.0 million in Q3 2025.